Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
37640
CAS Number:
54856-23-4
Betahistine methanesulfonate
Purity:
≥ 99% (Assay by titration, HPLC)
Synonym(s):
Betahistine mesylate, 2-[2-(Methylamino)ethyl]pyridine methanesulfonate
Documents
$158.94 /25G
Pack Size Availability Price
Request Bulk Quote
Product Information

Betahistine methanesulfonate is a well-regarded compound primarily utilized in the treatment of vestibular disorders, such as Ménière's disease. This compound acts as a histamine analog, enhancing blood flow to the inner ear, which can alleviate symptoms such as vertigo, tinnitus, and hearing loss. Its unique mechanism of action makes it particularly effective in improving balance and reducing the frequency of vertiginous episodes, thereby significantly enhancing the quality of life for patients suffering from these conditions.

In addition to its therapeutic applications, Betahistine methanesulfonate is also of interest in research settings, where it is studied for its potential neuroprotective effects and its role in modulating neurotransmitter release. Researchers and healthcare professionals appreciate its favorable safety profile and the absence of sedative effects, making it a preferred choice over other treatments for similar conditions. Its versatility and efficacy in managing vestibular disorders underscore its importance in both clinical and research environments.

Synonyms
Betahistine mesylate, 2-[2-(Methylamino)ethyl]pyridine methanesulfonate
CAS Number
54856-23-4
Purity
≥ 99% (Assay by titration, HPLC)
Molecular Formula
C8H12N2·2CH4O3S
Molecular Weight
328.4
MDL Number
MFCD00143688
PubChem ID
198334
Melting Point
112 - 115 °C
Appearance
White to almost white powder to crystal
Conditions
Store at 2 - 8 °C
General Information
Synonyms
Betahistine mesylate, 2-[2-(Methylamino)ethyl]pyridine methanesulfonate
CAS Number
54856-23-4
Purity
≥ 99% (Assay by titration, HPLC)
Molecular Formula
C8H12N2·2CH4O3S
Molecular Weight
328.4
MDL Number
MFCD00143688
PubChem ID
198334
Melting Point
112 - 115 °C
Appearance
White to almost white powder to crystal
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Betahistine methanesulfonate is widely utilized in research focused on:

  • Treatment of Vestibular Disorders: It is primarily used to alleviate symptoms of Meniere's disease and other vestibular disorders, helping patients manage vertigo and balance issues effectively.
  • Pharmaceutical Development: Researchers explore its pharmacological properties to develop new formulations that enhance bioavailability and patient compliance, particularly in oral dosage forms.
  • Neuroscience Research: It is studied for its potential neuroprotective effects, contributing to research on conditions such as tinnitus and other auditory processing disorders.
  • Clinical Trials: The compound is frequently involved in clinical trials aimed at assessing its efficacy and safety, providing valuable data for healthcare professionals and regulatory bodies.
  • Combination Therapies: It is investigated for use in combination with other medications to improve therapeutic outcomes for patients with complex conditions, offering a more holistic approach to treatment.

Citations